Genmab — Maj 2019
-
-
JNJ-7564 GPRC5D/CD3:
http://www.genmab.com/product-pipeline/products-in-development/jnj-63709178 -
Nu vi er ved det, så er det aldroig lykkedes mig at finde ud af, om dette også er med Genmab "JNJ-67371244 (Bispecific Antibody Targeting CD33 and CD3), in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) ???
-
interessant med JNJ. Det er midt to hig singel digit royalties på disse?
-
Hvorfor er den double? De er vel alle et produkt af samme aftale med de 20 antistoffer?
-
-
Har de bekræftet den er double? For typisk så er sådan nogle platforms aftaler 1-cifrede
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind